Aurinia Pharmaceuticals (AUPH) Current Leases (2020 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Current Leases came in at $1.6 million in Q1 2026, down 88.82% YoY from $14.5 million in Q1 2025, and down 90.18% on a QoQ basis from $16.5 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Current Leases (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 7 years of Current Leases data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Current Leases fell 88.82% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 88.82% YoY) and the FY2025 annual result came in at $16.5 million, up 1510.43% from the prior year.
- Current Leases slipped to $1.6 million in Q1 2026, from $16.5 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $16.5 million in Q4 2025 to a low of $918000.0 in Q3 2022.
- A 5-year average of $5.4 million and a median of $1.0 million in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases sank 92.98% — and 2025, when it jumped 1510.43%.
- Tracing AUPH's Current Leases over 5 years: stood at $918000.0 in 2022, then jumped by 1491.39% to $14.6 million in 2023, then sank by 92.98% to $1.0 million in 2024, then jumped by 1510.43% to $16.5 million in 2025, then sank by 90.18% to $1.6 million in 2026.
- The last three Current Leases figures came in at $1.6 million (Q1 2026), $16.5 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn | 16.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.48 Mn |
| Mar 31, 2026 | 1.62 Mn |
| Dec 31, 2025 | 16.52 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 14.51 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 14.93 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 13.72 Mn |
| Dec 31, 2023 | 14.61 Mn |
| Sep 30, 2023 | 980,000.00 |
| Jun 30, 2023 | 954,000.00 |
| Mar 31, 2023 | 945,000.00 |
| Sep 30, 2022 | 918,000.00 |
| Jun 30, 2022 | 953,000.00 |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.11 Mn |